Today’s AI Top Pick: KVYO
8/26/2026 · Swing Setup screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live KVYO price forecast →
Klaviyo (KVYO) is the cleanest multi-timeframe setup in the pool right now. Every horizon points up: the 4h forecast is +30.53% short / +50.28% mid, the 1d is +2.91% / +11.71% / +31.51% (short/mid/long), and the 1wk is +7.78% / +19.71% / +50.46%. That is true multi-timeframe agreement — not a single-bar outlier. bullish_prob is 1.0 and near_term_bullish is 1.0, the only name in the pool with both at max. Crucially, KVYO is NOT extended. Position in the 21-bar range is 71.75% on 4h but only 27.18% on 1d and 46% on 1wk, with a manageable -10.34% daily drawdown and -21.77% off the weekly high. That means you're buying a name that has already been de-risked on the higher timeframes — the exact opposite of CALX (1d pos 93.48%, 4h pos 94.83%) or GLXY/GENI/STEP which are pinned at 97%+ of range and screaming 'chase.' The screen already confirmed the fundamentals: fwdPe 16.64, peg 0.65, salesYoY 28.89%, epsNextY 28.28%, recom 1.26, targetUpsidePct 51.4% — reasonable multiple for a 29% grower with strong sell-side support. News flow is a tailwind, not a landmine. SeekingAlpha's Aug 20 note flagged 'Tremendous New Product Momentum,' and the company is actively hitting investor conferences on Aug 25 — no guidance cut, no dilution, no legal overhang. Contrast with SRAD (UBS downgrade Aug 5, price target cut to $16), KTOS (short-seller-style 'cash burn illusion' piece Aug 25), or NESR (already up 288% YoY with 4h forecasts of -37% to -44%). Today is the right entry because the 1d timeframe is still in the lower third of its range with rising short/mid/long forecasts — you get the higher-timeframe uptrend without paying the extension premium. Waiting risks the 4h continuing to lift into resistance and forcing a chase; the multi-TF forecast asymmetry (+31% to +50% long-horizon vs. ~11% shallow drawdown risk) is favorable RIGHT NOW.
- Extreme short interest at 22.48% float — a squeeze cuts both ways; sharp reversals possible on any weak print
- TTM PE of 830 and razor-thin profit margin (0.49%) mean any growth miss triggers severe multiple compression
- YTD performance -45.8% and 1yr -44.25% show the stock is in a downtrend regime; forecast-based bounce could stall at prior supply near $19-20
- Operating margin is still negative (-1.86%), so profitability inflection remains a 'show me' story
- Broader SaaS/ad-tech sentiment can reverse quickly; a market pullback likely takes this beta name down first
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | KVYO | BUY NOW | 8.5 | All-timeframe bullish forecasts with 1wk fc_long +50.46%, 1d position only 27% of range — best asymmetry in the pool. |
| 2 | HSAI | BUY NOW | 7.6 | Top fundamentals (score 8, peg 0.5, 14.76% profit margin) + strong near-term forecasts, but weekly outlook is negative — trade, don't marry. |
| 3 | SRAD | BUY NOW | 7.2 | Deep-oversold reversal (pos 0.31% on 4h) with fc_mid +60% on 4h; UBS downgrade is the caveat. |
| 4 | KC | BUY PULLBACK | 6.7 | 1d fc_mid +34.07% and Kingsoft loss-narrowing catalyst, but 4h is pinned at 99% of range — wait for a pullback. |
| 5 | CALX | BUY PULLBACK | 6.4 | Fundamental score 8 and 4h fc_short +37.6%, but 4h/1d pos ~94% is chasing; 1wk fc_short is -4.57%. |
| 6 | BTDR | BUY PULLBACK | 5.9 | Insider buying at $8.84 + 1d fc_long +27.64%, but 1d pos 97.84% and weekly drawdown -36.85% — not today's entry. |
| 7 | MIR | WAIT | 5.6 | 4h fc_long +56.9% is enticing but 1wk fc_mid -10.64% shows deteriorating higher-TF thesis. |
| 8 | TKC | BUY PULLBACK | 5.4 | Cheapest name (peg 0.16, fwdPe 5.83) with recom 1.0, but 1wk forecasts flat/negative and 4h pos only 14% — patient bid. |
| 9 | STEP | WAIT | 5.2 | Positive short-term forecasts but 4h pos 97.88% and 1wk fc_long -16.52% — extended and rolling over. |
| 10 | GLXY | WAIT | 5.0 | 1d pos 97.86%, 4h fc_mid -7.58%, and Citi lowered PT — needs to consolidate. |
| 11 | RARE | WAIT | 4.9 | FDA approval catalyst and 1wk fc_long +43%, but bullish_prob only 0.2 and near-term forecasts are barely positive. |
| 12 | KTOS | AVOID | 4.5 | 1wk fc_mid -39.2% and fc_long -48.61% with cash-burn narrative — screen passes but tape rejects. |
| 13 | VFS | WAIT | 4.3 | Deeply unprofitable (op margin -82.53%, profit margin -110.54%) with mixed forecasts; near_term_bullish only 0.2. |
| 14 | GENI | AVOID | 3.6 | 1wk pos 93% after 106% run and ALL forecasts negative — classic top-of-range exhaustion. |
| 15 | NESR | AVOID | 2.5 | Up 288% YoY with 4h forecasts -37% to -44%; parabolic exhaustion, only 4h data provided. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord